Quantum materials, materials exhibiting physical behavior governed by the laws of quantum mechanics, have proved promising ...

Sanofi’s Wayrilz approved in Japan to treat immune thrombocytopenia Wayrilz is a BTK inhibitor that works through multi-immune modulation to help ...

Epicrispr Biotechnologies, a clinical-stage company pioneering epigenetic therapies, today announced new interim data from ...

Modern OCT devices can look inside the eye without a scalpel - but they do not always capture everything that matters. Some ...

Tiziana Life Sciences Ltd (NASDAQ:TLSA) said the last patient in its Phase 2a clinical trial has received a first dose of ...

Novel immune reprogramming oral macrocyclic peptides designed for precise modulation of complex biological networks involved in inflammatory, ...

Newron Pharmaceuticals provides update following Type A meeting with the US FDA: Milan, Italy Saturday, July 4, 2026, 10:00 Hrs [IST] Newron Pharmaceuticals S.p.A. (Newron), a bio ...

A new approach for identifying signs of hidden awareness in people who cannot speak or move after severe brain injury has ...

Menstrual cycle phases influence heart autonomic regulation, showing HRV variations, yet muscle performance and mood states ...

Top line data readout expected in late Q3/early Q4; INFORM-MS trial is a randomized, double-blind, placebo-controlled Phase ...

Diets rich in sugars and fats are associated with metabolic disorders such as insulin resistance, chronic inflammation and ...

In adolescents, the most common adverse events (occurring in =5% of ML-004-treated adolescents and at least twice the rate of placebo) were headache (13.7% vs. 3.9%), somnolence (11.8% vs. 0%), nausea ...